Heron Therapeutics, Inc. (HRTX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1155504,
    "name": "Heron Therapeutics, Inc.",
    "stock_name": "Heron Therapeutics, Inc.",
    "full_name": "Heron Therapeutics, Inc.",
    "name_url": "stocks-analysis/heron-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.31",
    "chg": 0.14,
    "chgp": "11.97%",
    "dir": 1,
    "prev_price": "1.17",
    "mcapval": "199.28",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US4277461020",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.21 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/heron-therapeutics-inc-1155504-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Heron Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-heron-therapeutics-inc-technically-bullish-or-bearish-3544679",
        "imagepath": "",
        "date": "2025-09-20 18:53:48",
        "description": "As of 25 August 2025, the technical trend for Heron Therapeutics, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with a weak strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from the KST on both weekly and monthly periods. Additionally, Bollinger Bands are indicating a bearish trend on the monthly timeframe. \n\nIn terms of performance, Heron has underperformed significantly against the S&P 500, with a year-to-date return of -15.69% compared to the S&P 500's 12.22%, and a one-year return of -33.85% versus the S&P 500's 17.14%...."
      },
      {
        "title": "Is Heron Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-heron-therapeutics-inc-overvalued-or-undervalued-3541412",
        "imagepath": "",
        "date": "2025-09-20 17:25:20",
        "description": "As of 23 February 2017, the valuation grade for Heron Therapeutics, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -11.26, an EV to EBIT of -124.99, and an EV to EBITDA of -365.76. \n\nIn comparison to its peers, Heron Therapeutics has a significantly worse EV to EBITDA ratio of -199.28, while Black Diamond Therapeutics, Inc., which is rated attractive, has a positive EV to EBITDA of 6.85. Additionally, Harpoon Therapeutics, Inc. shows a less negative EV to EBITDA of -13.41, highlighting the challenges faced by Heron in its industry. The stock has underperformed relative to the S&P 500, with a YTD return of -15.69% compared to the index's 12.22%, reinforcing the notion of overvaluation...."
      }
    ],
    "total": 7,
    "sid": "1155504",
    "stock_news_url": "https://www.marketsmojo.com/news/heron-therapeutics-inc-1155504"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Heron Therapeutics, Inc. technically bullish or bearish?

2025-09-20 18:53:48

As of 25 August 2025, the technical trend for Heron Therapeutics, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with a weak strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from the KST on both weekly and monthly periods. Additionally, Bollinger Bands are indicating a bearish trend on the monthly timeframe. In terms of performance, Heron has underperformed significantly against the S&P 500, with a year-to-date return of -15.69% compared to the S&P 500's 12.22%, and a one-year return of -33.85% versus the S&P 500's 17.14%....

Is Heron Therapeutics, Inc. overvalued or undervalued?

2025-09-20 17:25:20

As of 23 February 2017, the valuation grade for Heron Therapeutics, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -11.26, an EV to EBIT of -124.99, and an EV to EBITDA of -365.76. In comparison to its peers, Heron Therapeutics has a significantly worse EV to EBITDA ratio of -199.28, while Black Diamond Therapeutics, Inc., which is rated attractive, has a positive EV to EBITDA of 6.85. Additionally, Harpoon Therapeutics, Inc. shows a less negative EV to EBITDA of -13.41, highlighting the challenges faced by Heron in its industry. The stock has underperformed relative to the S&P 500, with a YTD return of -15.69% compared to the index's 12.22%, reinforcing the notion of overvaluation....

View All News